PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Dr. David A. Schwartz receives 39th annual Alton Ochsner Award

Dr. David A. Schwartz receives 39th annual Alton Ochsner Award
2024-08-28
(Press-News.org) NEW ORLEANS – Ochsner Health has announced David A. Schwartz, MD, as the 2024 winner of the Alton Ochsner Award Relating Smoking and Disease. Dr. Schwartz is a Distinguished Professor of Medicine and Immunology and director of the Program to Advance Physician Scientists and Translational Research at University of Colorado’s Anschutz School of Medicine. 

Dr. Schwartz won the 39th annual Alton Ochsner Award for his research on how genetic and environmental factors, including smoking, contribute to idiopathic pulmonary fibrosis (IPF). He found that a specific change in the MUC5B gene increases the risk of developing IPF. Smoking can increase this risk by three to five times and activates the MUC5B gene. This discovery helps identify people at risk for IPF early, even before any symptoms appear; advances novel mechanisms of disease pathogenesis; and suggests new ways to treat all forms of a disease that has limited therapeutic options. 

“I am honored to be recognized for our contributions to lung fibrosis,” said Dr. Schwartz. “My team at the University of Colorado and my collaborators around the world have made these discoveries possible. We are hopeful that our recent advances in the way we think about this progressive disease will ultimately benefit patients with lung fibrosis.” 

The prestigious award, established in 1986, recognizes groundbreaking scientific research that deepens our understanding of the biological mechanisms linking tobacco smoking and human disease. Honoring Dr. Alton Ochsner, who first identified smoking as a primary cause of lung cancer in 1939, the award includes a $15,000 honorarium, an award medallion, and a plaque detailing the recipient's key research findings. This accolade continues Dr. Ochsner's legacy by highlighting exemplary contributions that advance the fight against smoking-related diseases. 

"We are honored to support researchers who make critical advancements to deepen our understanding of smoking cessation and disease prevention, because we know research is key to unlocking innovative treatments,” said Leonardo Seoane, MD, Chief Academic Officer for Ochsner Health. “We commend Dr. Schwartz for his scientific discoveries that will help physicians screen for and treat idiopathic pulmonary fibrosis.” 

To learn more about the award or see past recipients visit research.ochsner.org/opportunities/research-awards/the-alton-ochsner-award-relating-smoking-and-disease.  

 

### 

 

About Ochsner Health  

Ochsner Health is the leading nonprofit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 13 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.  

END


[Attachments] See images for this press release:
Dr. David A. Schwartz receives 39th annual Alton Ochsner Award Dr. David A. Schwartz receives 39th annual Alton Ochsner Award 2 Dr. David A. Schwartz receives 39th annual Alton Ochsner Award 3

ELSE PRESS RELEASES FROM THIS DATE:

New data: Solar at K-12 schools quadrupled nationwide during the last ten years

New data: Solar at K-12 schools quadrupled nationwide during the last ten years
2024-08-28
Charlottesville, VA — Schools across the country are rapidly switching to solar power to meet their energy needs while gaining significant cost-savings, boosting climate resilience, and supporting workforce development, according to a new report from clean energy nonprofit Generation180. Since the start of 2014, the amount of solar capacity installed at K-12 schools has more than quadrupled nationwide. According to Brighter Future: A Study of Solar on K-12 Schools, 5th edition, over 6.2 million U.S. K-12 students– or more than one in nine students – now attend a school that utilizes solar power. In 2022-2023, over 800 schools added solar arrays, which is enough ...

Thermochromic material could make indoor temperature control more energy-efficient

Thermochromic material could make indoor temperature control more energy-efficient
2024-08-28
HOUSTON – (Aug. 28, 2024) – Rice University researchers have developed a smart material that adjusts its transparency with changes in temperature, outperforming similar materials in terms of durability, transparency and responsiveness. The new polymer blend could significantly enhance energy efficiency for indoor space cooling, according to a new study published in Joule. Cooling off can be a matter of life or death, but air conditioning ⎯ when and if available ⎯ already accounts for 7% of the world’s energy use and 3% of carbon emissions. With temperatures hitting record ...

Damon Runyon Cancer Research Foundation awards $4.8 million to exceptional early-career scientists

2024-08-28
The Damon Runyon Cancer Research Foundation has named 16 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. This prestigious Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total) to investigate cancer causes, mechanisms, therapies, and prevention. “What is so exciting—and so challenging—about being a postdoc is that you’re called to take what you know and apply ...

Primary care providers urged to assist patients who engage in emotional eating

2024-08-28
August 28, 2024 — Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts. According to their article published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer, emotional eating is associated with myriad health problems, including the experience of ...

Half of Uber, Lyft trips replace more sustainable options

Half of Uber, Lyft trips replace more sustainable options
2024-08-28
More than 50% of ride-hailing trips taken by surveyed riders in California replaced more sustainable forms of transportation — such as walking, cycling, carpooling, and public transit — or created new vehicle miles, according to a study from the University of California, Davis Institute of Transportation Studies.  The study was conducted to help guide development of the Clean Miles Standard, a state regulation designed by the California Air Resources Board to reduce the greenhouse gas emissions from ride-hailing services.  Published in Transportation Research ...

miR-10b Inhibition: A strategy for treating metastatic breast cancer

miR-10b Inhibition: A strategy for treating metastatic breast cancer
2024-08-28
“We have developed a nanodrug, termed MN-anti-miR10b, that delivers anti-miR-10b antisense oligomers to cancer cells.” BUFFALO, NY- August 28, 2024 – A new research paper was published in Oncotarget's Volume 15 on August 26, 2024, entitled, “Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties.” As stated within the Abstract of the paper, despite advances in breast cancer screening and treatment, the prognosis for metastatic disease remains dismal, with ...

Love is blind for male fruit flies who will choose sex over safety

Love is blind for male fruit flies who will choose sex over safety
2024-08-28
Male fruit flies will become oblivious to physical danger as they become more engaged in courtship and sex, new research shows. Researchers at the University of Birmingham have shown that pursuit of a coveted reward – in this case a female fly – will cause a male fruit fly to ignore threats such as predation. In the study, published today (28 Aug) in Nature, the team was able to show for the first time the neural networks in the fly’s brain that direct this decision-making process, revealing the neurotransmitter dopamine has a leading role to play. Lead researcher Dr Carolina Rezaval said: “Every day we make decisions that require us to ...

Kidney donors’ risk of death at all-time low

2024-08-28
The risk of death for people who donate a kidney for transplantation — already small a decade ago — has dropped by more than half since then, a new study shows. Each year, roughly 6,000 Americans volunteer to donate a kidney, according to the Organ Procurement and Transplantation Network. Before undergoing the procedure, donors are informed of the potential risks, including death. Based on data from 1995 through 2009, experts had originally predicted that about three of every 10,000 donors were likely to die within three months of the procedure. The authors of the ...

Thirty-year trends in perioperative mortality risk for living kidney donors

2024-08-28
About The Study: Perioperative mortality after living donation declined substantially in the past decade compared with prior decades, to fewer than 1 event per 10,000 donations. Risk was higher for male donors and donors with a history of hypertension. Current guidelines for donor informed consent, based on 2009 data, should be updated to reflect this information. Corresponding Author: To contact the corresponding author, Dorry L. Segev, MD, PhD, email dorry.segev@nyulangone.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.14527) Editor’s Note: Please ...

Intersection of poverty and rurality for early-onset colorectal cancer survival

2024-08-28
About The Study: Patients with early-onset colorectal cancer (defined as colorectal cancer diagnosed in individuals younger than 50 years) living in rural areas had lower 5-year survival rates than their urban dwelling counterparts in this study. While it was not observed consistently for all age groups, persistent poverty in these rural areas may compound this association. Corresponding Author: To contact the corresponding author, Meng-Han Tsai, PhD, metsai@augusta.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.30615) Editor’s Note: Please ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Dr. David A. Schwartz receives 39th annual Alton Ochsner Award